A randomized clinical trial of hydroxymethylglutaryl-Coenzyme A reductase inhibition for Acute Lung Injury (The HARP study)

Medicine and Dentistry

• Acute Lung Injury 100%
• Adverse Event 16%
• Artificial Respiration 16%
• Biological Product 16%
• Breathing Mechanics 16%
• Bronchoalveolar Lavage Fluid 16%
• C Reactive Protein 33%
• Combination Therapy 16%
• Cytokine 16%
• Diseases 16%
• Drug Therapy 16%
• Hydroxymethylglutaryl Coenzyme A Reductase 16%
• Inpatient 16%
• Intensive Care Unit 16%
• Lung 33%
• Lung Lavage 16%
• Measurement 16%
• Mortality 16%
• Organ 50%
• Patient 33%
• Placebo 50%
• Plasma 50%
• Randomized Clinical Trial 16%
• Serositis 50%
• Simvastatin 100%
• Statin 16%
• Therapeutic Procedure 16%
• Water 33%